Last reviewed · How we verify
Combined Therapy of Posterior Subtenon Triamcinolone Acetonide and Intravitreal Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
This study compares the efficacy of intravitreal bevacizumab monotherapy only or combined therapy of posterior subtenon's triamcinolone acetonide and intravitreal bevacizumab for the treatment of macular edema associated with branch retinal vein occlusion.
Details
| Lead sponsor | Yeungnam University College of Medicine |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 45 |
| Start date | 2012-01 |
| Completion | 2012-08 |
Conditions
- Branch Retinal Vein Occlusion
Interventions
- intravitreal bevacizumab monotherapy
- combined therapy of posterior subtenon triamcinolone acetonide and intravitreal bevacizumab injection
Primary outcomes
- Changes of Central Retinal Thickness — baseline, 1, 3, 6 months after injection
Changes of central retinal thickness on optical coherence tomography (OCT) at baseline and 1, 3, 6 month after injection
Countries
South Korea